Kenneth Krogulski - 17 Oct 2023 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
17 Oct 2023
Transactions value $
$5,753
Form type
4
Filing time
03 Nov 2023, 17:02:00 UTC
Previous filing
17 Oct 2023
Next filing
17 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $627 +280 +0.13% $2.24 222,473 17 Oct 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $549 +280 +0.13% $1.96 222,753 18 Oct 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $574 +280 +0.13% $2.05 223,033 19 Oct 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $133 +64 +0.03% $2.08 223,097 20 Oct 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $530 +255 +0.11% $2.08 223,352 23 Oct 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $588 +280 +0.13% $2.10 223,632 24 Oct 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $557 +280 +0.13% $1.99 223,912 25 Oct 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $557 +280 +0.13% $1.99 224,192 26 Oct 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $554 +280 +0.12% $1.98 224,472 27 Oct 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $520 +255 +0.11% $2.04 224,727 30 Oct 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $563 +280 +0.12% $2.01 225,007 31 Oct 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023.